Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

BACKGROUND: Androgen deprivation therapy (ADT) is foundational in the management of advanced prostate cancer (PCa) and has benefitted from a recent explosion in scientific advances. These include approval of new therapies that suppress testosterone (T) levels or inactivate its function, improvements...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, E. David, Heidenreich, Axel, Lawrentschuk, Nathan, Tombal, Bertrand, Pompeo, Antonio C. L., Mendoza-Valdes, Arturo, Miller, Kurt, Debruyne, Frans M. J., Klotz, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370592/
https://www.ncbi.nlm.nih.gov/pubmed/30131604
http://dx.doi.org/10.1038/s41391-018-0079-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370592/
https://www.ncbi.nlm.nih.gov/pubmed/30131604
http://dx.doi.org/10.1038/s41391-018-0079-0

Ejemplares similares